Skip to content

Clinical trials

Primary Myelofibrosis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Country / region: Italy Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20054
20075
20081
20091
20102
20114
20121
20136
20143
20153
20162
20178
20182
20196
20207
202115
20225
20235
20249
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Active, not recruiting19
Recruiting18
Terminated11
Unknown status7
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals14
Incyte Corporation10
AbbVie6
Celgene5
European Organisation for Research and Treatment of Cancer - EORTC4
Kartos Therapeutics, Inc.4
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS3
Fondazione IRCCS Policlinico San Matteo di Pavia3
Icahn School of Medicine at Mount Sinai3
Italfarmaco3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis100
Myeloproliferative Disorders31
Thrombocythemia, Essential26
Polycythemia Vera25
Neoplasms10
Anemia9
Leukemia, Myeloid, Acute9
Hematologic Diseases6
Lymphoma, Follicular6
Lymphoma, Non-Hodgkin6

Trials

Showing 51 to 75 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.